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Modulation of Igβ is essential for 
the B cell selection in germinal 
center
Kagefumi Todo, Orie Koga, Miwako Nishikawa & Masaki Hikida
The positive and negative selection of antigen-reactive B cells take place in the germinal center 
(GC) during an immune responses. However, the precise molecular mechanisms underlying these 
selection machineries, including the involvement of antigen receptor signaling molecules, remain to 
be elucidated. We found that expression levels of Igα and Igβ , which are the essential components of 
B cell antigen-receptor complex, were differentially regulated in GC B cells and that the expression 
of Igβ was more prominently down-regulated in a portion of GC B cells. The suppression of Igβ 
down-regulation reduced the number of GL7+GC B cells and the affinity maturation in T-dependent 
responses was markedly impaired. In addition, the disease phenotypes in autoimmune-prone mice 
were ameliorated by blocking of Igβ down-regulation. These results suggest that Igβ down-regulation 
is involved in the normal positive selection in GC and the accumulation of autoreactive B cells in 
autoimmune-prone mice.
The B cell antigen receptor (BCR) is a protein complex that consists of a membrane-bound immunoglob-
ulin (Ig) molecule and the signal transducer, an Igα /Igβ hetero-dimer, and other signaling molecules1–3. 
It is well known that the Igα /Igβ hetero-dimer is required for the expression of membrane-bound Igμ 
chains on the surface of preB cells1,4,5. Furthermore, Igμ chains expressed on the cell surface of B lineage 
cells in association with Igα /Igβ hetero-dimer play essential roles in both differentiation and survival of 
preB cells and mature B cells6,7. In addition, it has been shown that cell surface expression of the Igα /
Igβ hetero-dimer not only supports the expression of cell surface Igμ chains, but also the signal through 
this complex is further required for the differentiation and survival of B lineage cells8–10. Hence, it has 
been widely believed that both Igα and Igβ are expressed in B lineage cells during all maturation stages.
After completion of differentiation, mature B cells participate in the humoral immune responses. One 
of the hallmarks of the humoral immune response is the formation of germinal centers (GCs) following 
the activation of B cells by an antigen under the influence of T cells11–13. It is widely known that GC 
B cells can be classified into two compartments namely centroblasts and centrocytes. Centroblasts are 
observed in the dark zone and they lack or express only low levels of surface Ig. These cells proceed with 
somatic hypermutation of their antibody variable genes and proliferate rapidly, which contribute to the 
clonal expansion. In contrast, centrocytes are relatively small non-dividing cells with surface Ig in the 
light zone where positive and negative selection take place14. A combination of somatic hypermutaion, 
clonal expansion, and selection leads a part of GC B cells to acquire a BCR with higher affinity for the 
antigen, which results in the affinity maturation of serum antibodies. It has been widely shown that a 
portion of GC B cells, mainly consisting of centroblasts, reduces their surface BCR expression during 
these processes. Thus, it can easily be predicted that BCR-associating molecules, including Igα and Igβ , 
are down-regulated in these cells. Indeed, it has been reported that expression of both Igα and Igβ was 
down-regulated in the germinal center (GC) B cells15–17. However, it has not been determined whether 
the modulation of these signaling molecules has as-yet-unknown physiological roles or simply reflects 
BCR down-regulation.
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In this study, we demonstrated that expression levels of Igα and Igβ , were differentially regulated in 
GC B cells and that the expression of Igβ was more prominently down-regulated in a part of GC B cells. 
Furthermore, this down-regulation of Igβ is involved both in the effective positive selection in GC B cells 
and the accumulation of autoreactive B cells in autoimmune-prone mice.
Results
The expression of Igβ is down-regulated in GC B cells. It has been reported that Igβ is ubiq-
uitously expressed in both immature and mature B cells. However, it has not been fully investigated 
whether Igβ is also expressed constantly in B cells during immune responses, such as in GC B cells. 
To clarify this point, we initially analyzed the expression of Igβ in the spleen from immunized mice by 
immunohistochemical staining. Ten days post immunization with NP-CGG, PNA+CD38− GCs were 
clearly detected (Fig.  1a). When compared with the follicular B cells, B cells in GCs were only weakly 
stained by anti-Igβ antibodies (Fig.  1a). Spleen cells from immunized mice were further analyzed by 
flow cytometer to confirm the down-regulation of cell surface Igβ . As shown in Fig.  1b, naïve B cells 
(B220+CD38+IgM+) expressed Igβ at high levels (MFI = 9.7 × 103), as expected. In contrast, the lev-
els of Igβ decreased in GC B cells identified with either surface markers CD38 or GL7 (B220+CD38−: 
MFI = 2.1 × 103 and B220+GL7+: MFI = 3.5 × 103). Quantitative RT-PCR revealed that the level of Igβ 
mRNA in non-apoptotic GC B cells was reduced by approximately 50% of that in naïve B cells (Fig. 1c), 
suggesting that the cell surface expression of Igβ is controlled at the transcription level to some extent. 
According to a previous report15 and the present data (see below), the expression of Igβ in GC B cells 
clearly correlated with the down-modulation of IgM. Thus, to clarify whether this down-regulation of 
Igβ in GC B cells simply reflects the decrease of surface BCR expression, we examined the levels of Igβ 
mRNA following the endocytosis of BCR in vitro (Fig.  1d). In comparison with the decreased surface 
IgM levels after BCR cross-linking, expression of Igβ mRNA was sustained at a constant level. Although 
cell surface level of Igβ correlates well with the endocytosis of IgM, these results suggest that there is an 
additional regulatory mechanism for the down-regulation of Igβ mRNA in vivo independent from BCR 
endocytosis induced by simple cross-linking (see below).
GC B cells can be classified into several stages based on their surface Igβ expression. When 
B220+CD38− B cells from immunized mice were analyzed for GL7 expression, the resulting population 
could be classified into GL7+ and GL7− subsets (Fig. 2a, left). Both of these subsets were IgD−, another 
GC B cell marker, suggesting that these subsets are both GC B cells (Fig. 2b). The B220+CD38−GL7+B 
cells formed a unique subset whose expression level of Igβ was 1/4 to 1/5 of that in B220+CD38+ naive 
B cells (Fig. 2a, right bottom). In contrast, CD38−GL7− B cells could be further divided into three sub-
populations based on their surface level of Igβ . Approximately 23% of the CD38−GL7− cells expressed 
Igβ at a level similar to that in naive B cells (Igβ -Hi cells), 43% of CD38−GL7− B cells expressed Igβ at 
a level of 1/8 to 1/10 of the level in naïve B cells (Igβ -Int cells), and 34% of these cells did not express 
or, at most, expressed low levels of Igβ (Igβ -Lo cells) (Fig. 2a, right bottom). In contrast, the cell surface 
expression of Igα was only slightly down-regulated in the CD38−GL7− B cell subset (MFI = 42.2) as 
compared with naive B cells (MFI = 55.7), and the level of Igα was not down-regulated in CD38−GL7+B 
cells (MFI = 65.8) (Fig. 2c). These results are consistent with the previous histological analysis of human 
lymph nodes reported by others17, strongly suggesting that expression of Igα and Igβ are differentially 
regulated in GC B cells.
To further confirm that this B220+CD38−GL7− population represents the subsets of GC B cells, we 
analyzed the expression of Bcl6 and AID (Fig. 2d, left). The expression of Igβ mRNA correlated well with 
the cell surface Igβ level, which again suggests that Igβ expression in GC B cells is regulated primarily 
at the transcription level. Bcl6 and AID were highly expressed in the Igβ -Hi, Igβ -Int and GL7+ cells. 
These results clearly demonstrate that the Igβ -Hi and Igβ -Int B cell subsets were indeed GC B cells. We 
also examined the expression level of Fas, which has been reported to be expressed in activated and GC 
B cells18,19 (Fig. 2d, right). High levels of Fas expression were detected in a majority of the GL7+B cells. 
Among the GL7− subpopulation, the Igβ -Int population significantly up-regulated Fas expression sug-
gesting that they are either a part of the GC B cells or at least of the activated B cells. We also checked 
the expression level of PD-1 in these cells and found that these Igβ -Int cells expressed only quite a low 
level of PD-1 (Fig. S1a), suggesting that Igβ -Int cells are a distinct population from the reported memory 
B cell fraction20. In addition, this B220+CD38−GL7− population was confirmed to be CD138− indicating 
that they were not plasma cell committed cells (data not shown). We further examined the expression 
levels of several known markers for GC B cells and memory B cells in B220+CD38−GL7− B cells and 
found that Igβ -Hi cells do not express memory surface markers (Fig. S1b)
To identify the proliferating cells among the aforementioned GC subpopulations, spleen cells from 
immunized mice were stained with the membrane-permeable DNA staining dye Hoechst33342 (Fig. 2e). 
Most IgM+CD38+B cells (> 90%) were in the G0/G1 phase and a small numbers of cell were in the S 
and G2/M phase (Fig.  2e, top). In contrast, a significant number of the GL7+B cells (6%-7%) were in 
the S + G2/M phase (Fig. 2e, bottom right). On the other hand, most of the cells in the S + G2/M phase 
were Igβ -Int cells belonging to the B220+CD38−GL7− population. Considering that GC B cells consisted 
of similar number of GL7+and GL7− populations (Fig. 2a, right bottom), these results may suggest that 
the major proliferating cells in the GC belong to the GL7−Igβ -Int B cell population (Fig. 2e, bottom left). 
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Furthermore, it was shown that most of the Igβ -Lo cells belonged to the sub-G0 phase indicating that 
these cells are apoptotic (Fig. 2e, bottom left).
We next examined the expression of surface Igβ in combination with surface IgG1 instead of GL7. 
The level of Igβ changed dramatically along with the acquisition of surface IgG1 in the B220+CD38− B 
cells, which prompted the need to analyze class switching in each population in detail (Fig. 3a, bottom). 
Figure 1. Down-regulated Igβ expression in the germinal center. (a) Frozen sections of the spleen from B6 
mice, 10 days after the immunization with NP-CGG precipitated in alum, were stained with PNA (green) 
and antibodies to Igβ (red) and CD38 (blue). (b) Naïve B cells (shaded), B220+CD38− cells (blue line) and 
B220+GL7+cells (red line) were analyzed for the expression level of Igβ . (c) Quantitative RT-PCR of Igβ 
mRNA in sorted naïve B cells (B220+IgM+CD38+) and GC B cells (B220+CD38−) from B6 mice 10 days 
after the immunization with NP-CGG. Cells were stained with propidium iodide to exclude dead cells and 
apoptotic cells. Data were normalized to the expression levels of the β -actin transcript. (d) Surface IgM in 
mouse splenic B cells was cross-linked with 10 ug/ml anti-IgM F(ab’)2 to induce endocytosis for indicated 
periods of time and remaining levels of cell surface IgM were analyzed (left). Expression levels of Igβ mRNA 
were analyzed by RT-qPCR in B cells whose surface IgM was down-modulated by cross-linking for the 
indicated periods (right).
www.nature.com/scientificreports/
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Figure 2. Classification of GC B cells by expression level of Igβ . (a) Flow cytometric analysis of splenocytes 
from immunized B6 mice. B220+B cells (left) cells were further gated to B220+CD38+cells (top right) and 
B220+CD38− cells (bottom right) and analyzed for the expression levels of Igβ and GL7. The numbers 
indicate the percentage of cells in each square, and the number in the parenthesis indicate the percentage 
of cells in each square within the CD38−GL7− cells. (b) Suppressed IgD expression in B220+CD38−GL7− 
and B220+CD38−GL7+B cells. (c) Expression of cell surface Igα in GC B cells. Cell surface expression 
levels of Igα and GL7 were examined in B220+CD38+naive B cells (top) and B220+CD38− GC B cells 
(bottom) by staining with anti-GL7 mAb in combination with rabbit polyclonal antibody raised against 
extracellular portion of Igα . Numbers indicate the percentages of the cells within the gates. (d) Transcription 
levels of Igβ , Bcl6 and AID in GC subsets (left) and surface Fas expression in B220+CD38−GL7− and 
B220+CD38−GL7+GC subsets (right). RT-qPCR were carried out in sorted B220+CD38−GL7−Igβ Hi 
cells (Igβ -Hi), B220+CD38−GL7−Igβ Int cells (Igβ -Int), B220+CD38−GL7−Igβ Lo cells (Igβ -Lo) and 
B220+CD38−GL7+cells (GL7+) 10 days after the immunization. (e) Cell cycle analysis of GC B cells. 
Splenocytes from immunized B6 mice were stained with Hoechst 33342 dye in combination with antibodies 
to Igβ and indicated surface markers, followed by FACS analysis. Naive B cells (top), B220+CD38−GL7− 
(bottom left) and B220+CD38−GL7+B cells (bottom right) were analyzed.
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Figure 3. Class switching events in GC B cells (a) Expression of IgG1 and Igβ in B220+IgM+CD38+naive B 
cells (top) and B220+CD38− GC B cells (bottom). (b) Expression levels of germline transcript and surface 
expression of IgM and IgG1 in the GC B cell subsets. Expression of IgM germline transcript (GLT-μ ), IgG1 
germline transcript (GLT-γ 1) and IgG1 postswitch transcript were assessed by RT-qPCR in each population, 
respectively (top). Cell surface expression of IgM and IgG1 in each GC subset was examined (bottom). 
(c) Frequency of somatic hypermutation in VH186.2 gene of GC B cell subsets. Number of nucleic acid 
mutations (left) and amino acid mutations (right) are shown.
www.nature.com/scientificreports/
6Scientific RepoRts | 5:10303 | DOi: 10.1038/srep10303
Thus, the expression of immunoglobulin mRNA was tested to clarify the class switching status of both 
GL7− and GL7+ subsets identified in Fig. 2a. As the result, high levels of Iμ germline transcripts were 
detected in the GL7− Igβ -Hi and Igβ -Int cells. Since it has been reported that Iμ germline transcripts 
were constitutively transcribed from the IgM locus in the germline configuration21 (Fig.  3b, top), it is 
apparent that these populations include IgM-bearing non class-switched B cells as a major population. 
Comparable levels of Iγ 1 germline transcripts and γ 1 post-switch transcripts were detected in Igβ -Int 
cells when compared with GL7+ cells (Fig. 3b, top). Since it has been reported that expression of germline 
transcripts take place prior to DNA rearrangement22, these results suggest that class switching from IgM 
to IgG1 may take place in both the GL7−Igβ -Int population and the GL7+ stage. In accordance with these 
data, nearly 90% of the cells in the GL7−Igβ -Hi population expressed IgM on their surface, including the 
population begining to down-regulate IgM (Fig. 3b, bottom left). In contrast, around 60% of the Igβ -Int 
population expressed only a low level of IgM and a portion of these cells (8.7%) begin to express a low, 
although significant, level of IgG1 on their surface and IgG1 single-positive cells were clearly detected 
in the GL7+ population (Fig.  3b, bottom right). According to a previous report23, the stimulation of 
IgM+B cells with anti-CD40 or CD40 ligand together with IL-4 induced only GL7+B cells concomitantly 
with class switching to IgG1. A straightforward interpretation for the previous and the aforementioned 
results is that, in addition to the population that became IgM−GL7+ class-switched cells following the 
IgM+GL7+ population, a significant portion of IgM+GL7− GC B cells might differentiate to IgM−GL7+ 
class-switched cells via the IgMdullGL7−Igβ -Int stage. Indeed, both IgM+GL7+ and IgMdullGL7− GC B cell 
subsets were detected (Fig. S2). This result may suggest the existence of a novel class-switching pathway 
distinct from in vitro class-switching where B cells differentiate from IgM+GL7− to IgMdullGL7+ switched 
B cells through IgM+GL7+B cells. In the in vitro system, it was shown that the considerable number of 
somatic hypermutations in the Ig gene were detected only when AID was over expressed23. This is con-
sistent with our results that Igβ -Int cells expressed higher level of AID (Fig. 2d).
To approach the speculation that Igβ -Int GL7− B cells may contribute to positive selection in 
the GC, the frequency of somatic hypermutation in each subset was analyzed (Fig.  3c). On day 10 
post-immunization of NP-CGG, nucleotide mutations in VH186.2 were readily detected in Igβ -Hi cells 
and the frequency slightly increased in the Igβ -Int and GL7+ cells, although the increase was not statisti-
cally significant (Fig. 3c, left). In parallel, amino acid replacements were significantly accumulated in the 
GL7+ cells as compared with Igβ -Hi cells. These results suggest that somatic hypermutations accumulate 
throughout the CD38− stage, including both the GL7− and GL7+ populations, and that affinity matura-
tion may proceed in the Igβ -Int cells (Fig. 3c, right).
Blocking of Igβ down-regulation in GC B cells impairs GC formation, efficient Ig production 
and affinity maturation. To further evaluate the physiological roles of Igβ down-regulation, B 
cell-specific Igβ -transgenic (Igβ -Tg) mice were generated (Fig. S3). Between the established two Tg lines, 
the line with higher expression of exogenous Igβ (line #1) was primarily analyzed. Over all differentiation 
of B cells in these mice was normal, except an increase in B220dullCD43− pre-B cells was observed (Fig. 
S3d). Furthermore, there were no significant differences in spontaneous Ig titers between transgenic mice 
and wild-type littermate controls (Fig. S3e). In addition, endocytosis of IgM complex by cross-linking of 
BCR was not affected in these transgenic mice (data not shown).
Frequency of Igβ down-regulated cells in the B220+CD38−GL7− B cells from the immunized Igβ -Tg 
mice (28.3%) decreased significantly compared to that in the wild-type littermate controls (74.9%), 
which is consistent with the results obtained in C57BL/6 mice (Figs. 4a and 2a). This finding indicates 
that the transgene was expressed in the expected manner, allowing us to analyze the function of Igβ 
down-regulation in GC B cells.
Next, the frequency of the GC B cell subsets defined above was enumerated. Normal GC forma-
tion was observed by histochemical analysis (Fig. S3f). The frequency of B220+CD38−GL7+ cells in the 
immunized spleen of the Igβ -Tg mice decreased to approximately 56% of that of wild-type mice (0.69% 
to 0.24%) (Fig. 4b top). In addition, the cell cycle status of the B220+CD38−GL7− B cells was examined 
and the proportion of proliferating cells was reduced from 10.8% to 4.4% (Fig. 4b, bottom).
These results suggest the involvement of Igβ down-regulation in the differentiation of GC B cells to 
proliferating cells, which may affect clonal expansion and subsequent affinity maturation. To investigate 
this possibility, NP-specific Ig titers and their relative affinity in Igβ -Tg mice following immunization 
with NP-CGG were examined. As the result, there were modest reductions in the NP-specific IgM and 
IgG1 levels and the impairment was more prominent in the IgG2b and IgG2c levels in Igβ -Tg mice after 
both primary and secondary immunizations (Fig. 4c). On day 21 post-immunization, the relative affinity 
of IgG1 for NP hapten was significantly reduced in Igβ -Tg mice (Fig. 4d). Consistent with these data, the 
frequency of W33L replacement, which reflects the affinity maturation of the VH186.2 variable region to 
the NP hapten, among the over all mutations in the VH186.2 gene was reduced in Igβ -Tg mice (Fig. 4e).
Igβ down-regulation in GC B cells is partly mediated by IL-21. It has recently been reported that 
the absence of IL-21 signaling profoundly affects the T-dependent B cell response through the impair-
ment of the GC reaction including antigen-specific IgG titer and affinity maturation24–26. To examine 
the possibility that IL-21 may exert its function by modulating the Igβ level in GC B cells, it was first 
evaluated whether IL-21 has the potential to induce Igβ down-regulation in purified B cells. Activation 
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Figure 4. Forced expression of Igβ in B cells impaired the antibody production and affinity maturation. (a) 
Expression of Igβ in B220+CD38−GL7− splenocytes from immunized Igβ -Tg (Igβ -Tg; line) and wild-type 
litter mates (wild type; shaded). (b) Expression of CD38 and GL7 in B220+spleen cells from immunized 
wild type litter mates (top left) and Igβ -Tg mice (top right). Cell cycle analysis of CD38−GL7− GC B cells 
from wild type litter mates (bottom left) and Igβ -Tg mice (bottom right). Numbers indicate the percentages 
of cells in each gate. (c) Serum anti-NP titers in each isotype after the immunization. Igβ -Tg (open circle) 
and wild type litter mates (closed circle) were immunized with NP-CGG on day 0 (1°) and boosted 42 
d later (2°). Sera were collected at indicated day and assayed by ELISA as described in Methods section. 
Error bars indicate SEM for each group. Each group consists of 5 mice. Representative data from 3 repeated 
experiments is shown. (d) Affinity maturation of anti-NP IgG1 antibody in NP-CGG immunized Igβ -Tg 
(closed bar) and wild type litter mates (open bar). Error bars indicate SEM for each group. (e) Decreased 
frequency of somatic hypermutation in immunized Igβ -Tg mice. CD38−GL7+GC B cells were isolated from 
Igβ -Tg and wild type litter mates 21 days after the immunization. Total RNA was extracted and reverse 
transcribed to obtain cDNA samples. VH186.2 gene was then amplified and sequenced for the mutation 
analysis.
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by IL-4 and an anti-CD40 antibody for 6 days, with or without IL-21, revealed that the frequency of 
Igβ down-regulated cells increased in an IL-21 dose-dependent manner (Fig.  5a,b). When cell surface 
expression of CD138 was analyzed in these cells, up-regulation of CD138 was not detected in these Igβ 
down-regulated B cells (Fig. S1c, right). These results indicate that IL-21 has the potential to directly act 
on activated B cells to regulate Igβ expression.
To further examine the involvement of IL-21 in the down-regulation of Igβ in vivo, the expression 
level of Igβ in GC B cells from IL-21 receptor-deficient (IL-21R-KO) mice24 was analyzed. As shown 
in Fig.  5c, the down-regulation of Igβ was significantly impaired in the immunized IL-21R-KO mice. 
Furthermore, the frequency of CD38−GL7+B cells in the spleen from IL-21R-KO mice was reduced to 
approximately 50% as compared with that of wild type mice (0.51% to 0.25%) (Fig. 5d), accompanied by 
the reduction of proliferating (S + G2/M) Igβ -Int cells (13.5% to 9.4%) (Fig. 5e).
Taken together along with the in vitro data, these results suggest that IL-21 may act on B cells directly 
or indirectly to down-regulate the expression of Igβ in the GC, which may be required for the effective 
progression of the cell cycle in these cells and/or for differentiation to the proliferating population.
Blocking of Igβ down-regulation ameliorated autoimmune phenotype in BXSB-Yaa mice.. It 
has been reported that IL-21 plays an essential role in the phenotypes of BXSB-Yaa autoimmune-prone 
mice27,28. However, the precise mechanism of how IL-21 is involved in the generation and accumu-
lation of autoreactive B cells has not been fully elucidated. To examine whether IL-21-mediated Igβ 
down-regulation may contribute to the pathogenesis of BXSB-Yaa mice, Igβ -Tg mice were back-crossed 
to this strain. The percentage of Igβ -Int cells among the B220+CD38−GL7− GC B cell population in 
BXSB-Yaa mice was higher than in the wild type mice (56% to 41%), presumably due to the higher 
serum IL-21 level in BXSB-Yaa mice (Fig. 6a)27,28. When Igβ -Tg mice were back-crossed to BXSB-Yaa, 
their percentage decreased from 56% to 18.6% and that of Igβ -Hi cells increased reciprocally indicating 
that the Igβ transgene is expressed as expected in the BXSB-Yaa background (Fig.  6a). As shown in 
Fig. 6b,c, serum levels of anti-dsDNA IgG and proteinuria were ameliorated in BXSB-Yaa mice carrying 
the Igβ transgene. In addition, these mice tend to survive for a longer period compared with littermate 
BXSB-Yaa mice (Fig.  6d). Assuming that autoantibody-producing cells are derived from GC B cells29, 
these results suggest that the modulation of Igβ expression level affects not only positive selection, but 
also the accumulation of autoreactive B cells in the GC at least in the BXSB-Yaa back ground.
Discussion
In this study, we demonstrated quantitatively that the cell surface expression of Igβ was more promi-
nently lowered as compared with that of Igα in the murine GC B cells and that the inhibition of Igβ 
down-regulation resulted in the impairment of T-dependent immune responses. These results indicate 
that the down-regulation of Igβ in GC B cells is essential for optimal antibody production and affinity 
maturation. Firthermore, crossing Igβ -Tg mice with BXSB-Yaa autoimmune-prone mice ameliorated the 
pathogenic phenotype.
Clonal selection of GC B cells with different antigen specificities and/or affinities that were raised by 
the somatic hypermutation resulted in affinity maturation11,30. During this selection stage, each B cell 
did not continue to retain BCRs with different specificities and/or affinities on its surface simultaneously, 
and could change their BCR specificity promptly to be selected31. This leads to the hypothesis that there 
may exist a machinery that excludes pre-existing BCRs with low affinity from the cell surface. Based on 
previous reports that the concomitant expression of Igα and Igβ is required for the surface expression 
of IgM4–6, it can be assumed that the down-regulation of Igβ may contribute to the prompt clearance 
of surface IgM BCRs, most of which remain unmutated, in B cells that in turn start expressing mutated 
IgG in turn. Supporting this assumption, we have recently found that membrane-attached IgG1 can be 
expressed on the cell surface of GP2-293 cells and Igβ down-regulated Ramos B cells, in contrast to IgM 
which could not be expressed on the surface of these cells32.
It has been reported that somatic hypermutation plays an essential roles in the generation of autore-
active antibody-producing B cells in some case of SLE33–35. However, it was also revealed in these studies 
that in addition to the pathogenic somatic hypermutation, failure in the selection stage was also required 
for the onset of the diseases. When Igβ -Tg mice were crossed with BXSB-Yaa mice, the pathogenesis 
observed in these mice was ameliorated. Although the precise molecular mechanism underlying this 
ameliorated phenotype remains to be elucidated, it may be possible that in the Igβ -Tg background, class 
switching of GC B cells may proceeds preferentially through the IgM+GL7+Igβ -Hi population as in the 
case of in vitro class switching where expression of Igβ is sustained at a comparable level as the naive B 
cells (Fig. S2). Under such condition, a skewed positive selection for the self-antigen or affinity matura-
tion that may affect the autoimmune symptoms may be partly bypassed because down-regulation of Igβ 
seems to be required for these processes to proceed efficiently.
Although the physiological relevance of Igβ down-regulation is clear, it remains to be determined how 
the expression of Igβ is modulated. In this study, it was revealed that Igβ down-regulation in the GC B 
cells was modulated at least in part at the transcription level (Figs. 1c and 2d). Regarding the transcrip-
tion control elements in the Igβ promoter, three silencing motifs have been reported36,37. Among them, 
the most effective A+ T-rich upstream sequence has been reported to bind Oct-1 and Oct-237. Although 
these molecules are fascinating candidates for responsible taranscription factors, the direct involvement 
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Figure 5. Impaired GC formation by inhibition of IL-21-mediated Igβ down-regulation. (a) Expression of 
Igβ in activated splenic B cells supplemented with IL-21. Splenocytes depleted of T cells were cultured with 
IL4 (10 ng/ml), and anti-CD40 antibody (1 μ g/ml) supplemented with indicated concentrations of IL-21 
for 6 days. Expression levels of Igβ and GL7 were analyzed by flow cytomeric analysis. The numbers under 
the square gate indicate the percentages of Igβ down-regulated population in the gate. Representative data 
from 3 experiments is shown. (b) Average percentages and SEM of Igβ low cells from repeated experiments 
as in (a) were shown. (c) Flow cytomtric analysis of Igβ expression in B220+CD38−GL7− splenocytes 
from immunized wild type (shaded) and IL-21R-deficient (line) mice. (d) Flow cytometric analysis of the 
splenic B cells (B220+) from wild type litter mates (left) and IL-21R-deficient mice (right) 10 days after the 
immunization with NP-CGG. The numbers indicate the percentage of CD38−GL7+ cells within the gate. (e) 
Cell cycle analysis of B220+CD38−GL7− GC B cells from immunized IL-21R-deficient mice. Splenocytes 
from wild type litter mates (left) and IL21R-deficient mice (right) 10 days after the immunization were 
stained with Hoechst 33342 dye in combination with antibodies to Igβ .
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Figure 6. Amelioration of auto-reactive antibody production and proteinuria by suppression of Igβ 
down-regulation in BXSB-Yaa autoimmune prone mice. Igβ -Tg mice were back-crossed to BXSB-Yaa for 
9 generation and obtained male mice were subjected to further analyses. Serum titers in NZB and wild 
type C57BL/6 mice were also measured concomitantly as positive band negative controls, respectively. (a) 
Percentages of Igβ -Hi and Igβ -Int B cell population in B220+CD38−GL7− GC B cell subset from immunized 
C57BL/6 (open bars), BXSB-Yaa background wt (dark shaded bars) and Igβ -Tg (light shaded bars) mice are 
shown. (b) Serum titers of anti-dsDNA antibodies were measured in BXSB-Yaa background wt and Igβ -Tg 
mice at indicated ages. Each symbol indicate the serum levels for individual mouse. Thick lines indicate the 
average values and thin lines indicate SEM values. (c) Protineuria was measured at 20 weeks of age. Each 
circle indicate the serum levels for individual mouse. (d) Survival curve of BXSB-Yaa background wt and 
Igβ -Tg mice.
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of Oct-1 and/or Oct-2 in the regulatory mechanisms of Igβ down-regulation in GC B cells remains to 
be tested.
With regard to soluble factors that may modulate Igβ expression, it was also revealed that Igβ 
down-regulation is partly mediated by IL-21 (Fig. 5). In accordance with these results, IL-21R-deficent 
mice showed impairment in the development of GC B cells and in affinity maturation25,26,38–40. However, 
because the blockade of Igβ down-regulation was not complete in IL-21R-deficient mice, it is evident that 
IL-21-independent machinery also exists. Antigen receptors of GC B cells are believed to be cross-linked 
by the cognate antigen during positive selection, which may result in the internalization of the BCR with 
its associating molecules, including Igα and Igβ . Thus, in addition to transcriptional regulation, we can-
not completely rule out the possibility that post-translational modulation such as internalization, circula-
tion or degradation of Igβ in association with BCRs may also be involved in its down-regulation15–17,41,42. 
Indeed, existence of an as-yet-unknown mechanism for post-transcriptional modulation of Igβ expres-
sion, which differ from Igα , was suggested in human GC B cells17. The surface expression levels of Igα 
were not dramatically down-regulated in the B220+CD38−GL7− GC B cell population as compared with 
that of the B220 + CD38 + GL7− B cells, in contrast to the expression levels of Igβ . However, a population 
that was up-regulating the surface Igα level could be observed, suggesting that still-unknown, unique 
mechanism exists for the regulation of Igα . Despite the marginal down-regulation of Igα in GC B cells, 
a decrease in the Igα mRNA level in GC B cells was detected (data not shown). This also suggests the 
existence of post-transcriptional regulation in the case of Igα . However, as aforementioned, a simple 
explanation of our results mainly by endocytosis of the IgM BCR complex associating with Igα /Igβ 
heterodimer seems unlikely.
Methods
Mice and immunization. Igβ -Tg mouse was generated using pEMV4C8-Igβ , which consists of 
mouse Eμ enhancer, mouse VH4C8 promoter, rabbit β -globin intron followed by HA-tagged mouse Igβ 
cDNA and rabbit β -globin derived polyA signal. Expression vector was a generous gift from Dr. Takeshi 
Watanabe. Linearlized expression vector was microinjected to C57BL/6 blastocyst and 2 founder lines, 
which both possess 3 copies of transgene, were established (Fig. S3) (PhoenixBio). IL-21 receptor-deficient 
mice24 was provided from Drs. Warren J. Leonard and Katsutoshi Ozaki. Immunizations were carried out 
as described previously43. In brief, 8–12 weeks old C57BL/6 mice were injected i.p. with 100ug NP-CGG 
(Biosearch Technologies) adsorbed to 3 mg Imject Alum (Thermo Fisher Scientific) according to the 
manufacturer’s instructions. All experimental protocols were approved by animal research committee in 
the Graduate School of Medicine, Kyoto University and carried out in accordance with the guidelines for 
the animal experiments in Kyoto University.
Flow cytometry and histological analysis. All cells were stained with indicated combinations of 
antibodies, and analyzed with FACSAria II (BD Biosciences). Cells were stained in combination with 
propidium iodide (Sigma) to exclude dead cells as described previously43.
Frozen 8 μ m sections of spleens from immunized mice were subjected to immunohistochemical stain-
ing. In brief, sections were fixed with 1:1 mixture of methanol (Wako) and acetone (Wako), blocked with 
1% BSA in PBS for 1 h, and stained with indicated antibodies in PBS with 0.1% BSA for 1 h. Finally, the 
sections were washed and mounted with SlowFade Gold (Invitrogen). Stained sections were visualized 
using LSM 710 NLO confocal fluorescent microscope with ZEN software (ZEISS).
Quantitative RT-PCR and PCR for cloning. Total RNA from sorted splenic cells was extracted 
using TRIzol Reagent (Invitrogen). Then, cDNA was synthesized from total RNA using SuperScript 
III First-Strand Synthesis System (Invitrogen). Transcription levels of Igβ , Bcl-6, AID, germline tran-
script from Iμ locus (GLT-μ ), germline transcript from Iγ 1 locus (GLT-γ 1) and postswitch transcript 
of Cγ 1 were determined by quantitative RT-PCR using the LightCycler 480 SYBR Green I Master and 
LightCycler 480 system (Roche). Relative expression levels of mRNA were calculated compared to those 
of β -actin.
ELISA. Serum anti-NP antibody levels were measured by ELISA as described below. 96-well flat-bottom 
plates (Thermo Fisher Scientific) were coated with 10 μ g/ml NP54-BSA (Biosearch Technologies), and 
then the wells were blocked with 5-fold diluted Blocking-One (Nacalai Tesque). Appropriately diluted 
serum samples were added to the wells and incubated at room temperature for 2 h. The plates were 
washed and incubated for another 1 h with diluted anti-IgM, -IgG1, -IgG2c and -IgG2b antibodies con-
jugated with horse radish peroxidase (Bethyl Laboratories), respectively. Bound secondary antibody was 
assessed by incubation with ABTS substrate (Sigma-Aldrich). Absorbance at 405 nm (A405) in each well 
was measured.
For the analysis of affinity maturation, appropriately diluted serum samples were assayed using an 
NP4-BSA (Biosearch Technologys) -coated 96-well plate and an NP54-BSA-coated plate. The A405(NP4)/
A405(NP54) ratio was calculated as relative affinity.
Generation of polyclonal antibody to cell surface Igα.  Synthetic peptide corresponding to 89 to 
99 amino acids with a extra cystein residue at N-terminal (CPEVNKNHRGLY) was conjugated to KLH 
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and repeatedly immunized to the rabbits and the obtained anti-serum was affinity purified with the 
immunized peptide conjugated to BSA (Scrum). Specificity of the antibody was confirmed by western 
blot analysis of murine splenic B cells and surface staining of NIH/3T3 cells transfected with Igα , Igβ 
and single chain EGFP-Fcγ 1. Also it was confirmed that no other spleen cells except B220+ cells were 
stained with the antibody.
Analysis of somatic hypermutation. Total RNA from the sorted splenocytes of immunized C57BL/6 
or Igβ -Tg mice was extracted and reverse transcribed to obtain cDNA, which was subjected to PCR using 
KOD DNA polymerase (Toyobo) with VH186.2-specific VH186.2F and IgG1-specific IgG1R primers and 
cloned into the plasmid PCR-blunt TOPO (Invitrogen) to analyze the sequence of the VH gene.
Measurement of autoantibody and proteinuria. Serum anti-dsDNA titers were measured using 
mouse anti-dsDNA IgG ELISA kit (Alpha Diagnostic International Inc.) according to the manufactur-
er’s instruction. Proteinuria was measured using Albustix Reagent Strips (SIEMENS) according to the 
manufacturer’s instruction.
Antibody Manufacturer clone
anti-B220-APC-Cy7 BD Biosciences RA3-6B2
anti-CD38-PE eBioscience 90
anti-GL7-Alexa Fluor 647 eBioscience GL-7




streptavidin-Texas Red BD Biosciences -
anti-IgG1 BD Biosciences A85-1
anti-IgG1-Pacific Blue BD Biosciences A85-1
anti-CD79b-biotin BD Biosciences HM79b
PNA-FITC Seikagaku Kogyo -
Table 1. List of antibodies used in the experiments











postswitch Cγ 1-qPCRF CTCTGGCCCTGCTTATTGTTG





Table 2. List of the oligos used in the experiments
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Antibodies and oligo nucleotides. Antibodies and oligo nucleotides used in this study were listed 
in Table 1 and Table 2, respectively.
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